Cellular and Molecular Neurobiology

, Volume 35, Issue 1, pp 115–121 | Cite as

Association of rs62063857 Variant of the Saitohin Gene with Parkinson’s Disease

  • Ezgi Sonmez
  • Mavi Deniz Ozel
  • Eylul Ece Islek
  • Ali Sazci
  • Halil Atilla Idrisoglu
Original Research


Saitohin gene found within the tau gene is thought to play a role in the pathogenesis of neurodegenerative diseases. The rs62063857 polymorphism originally found in the saitohin gene seems to be the responsible SNP in this event. This polymorphism is studied mostly in patients with Alzheimer’s disease. Data on Parkinson’s disease are scarce. Therefore, we examined the rs62063857 polymorphism in 583 Parkinson’s disease patients (347 male and 236 female) and 396 healthy controls (238 male and 158 female) by a polymerase chain reaction and restriction fragment length polymorphism method to see whether it was associated with Parkinson’s disease from the City of Istanbul, Turkey. The G allele frequency was 22 % in overall controls and 16 % in Parkinson’s disease patients. In this study, the saitohin rs62063857 polymorphism was associated with Parkinson’s disease (χ2 = 16.765; P = 0.000). Individuals with the AA genotype showed 1.7-fold increased risk for Parkinson’s disease (χ2 = 16.680; P = 0.000), whereas individuals with the AG genotype revealed protection against Parkinson’s disease (χ2 = 14.554; P = 0.000). After the stratification analysis according to gender, both male and female PD patients showed association with the alleles and genotypes of the rs62063857 polymorphism of the saitohin gene (χ2 = 9.476, P = 0.009; χ2 = 7.593, P = 0.022, respectively). When the Parkinson’s patients were divided into two groups with regard to onset of the disease, both groups showed association with the disease. The Parkinson’s patients with disease onset below 65 years of age showed 1.8-fold increased risk for the disease. The Parkinson’s patients with disease onset over 65 showed more robust association with a 2.051-fold increased risk for the disease. Consequently, the rs62063857 polymorphism of the saitohin gene is a genetic risk factor for Parkinson’s disease. Hence, this polymorphism may play a role in the etiology of Parkinson’s disease.


Parkinson’s disease Saitohin gene Q7R polymorphism rs62063857 Association Disease onset Neurodegenerative disease Turkey 



The study presented herein is done using the departmental resources.

Conflicts of interest

The authors declare that they have no conflicts of interest. They also declare that all authors were fully involved in the study and preparation of the manuscript.


  1. Andreadis A (2012) Tau splicing and the intricacies of dementia. J Cell Physiol 227(3):1220–1225PubMedCentralPubMedCrossRefGoogle Scholar
  2. Baker M, Litvan I, Houlden H, Adamson J, Dickson D, Perez-Tur J, Hardy J, Lynch T, Bigio E, Hutton M (1999) Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet 8(4):711–715PubMedCrossRefGoogle Scholar
  3. Bosia M, Buonocore M, Guglielmino C, Pirovano A, Lorenzi C, Marcone A, Bramanti P, Cappa SF, Aguglia E, Smeraldi E, Cavallaro R (2012) Saitohin polymorphism and executive dysfunction in schizophrenia. Neurol Sci 33(5):1051–1056PubMedCrossRefGoogle Scholar
  4. Clark LN, Levy G, Tang MX, Mejia-Santana H, Ciappa A, Tycko B, Cote LJ, Louis ED, Mayeux R, Marder K (2003) The Saitohin ‘Q7R’ polymorphism and tau haplotype in multi-ethnic Alzheimer disease and Parkinson’s disease cohorts. Neurosci Lett 347(1):17–20PubMedCrossRefGoogle Scholar
  5. Combarros O, Rodero L, Infante J, Palacio E, Llorca J, Fernández-Viadero C, Peña N, Berciano J (2003) Age-dependent association between the Q7R polymorphism in the Saitohin gene and sporadic Alzheimer’s disease. Dement Geriatr Cogn Disord 16(3):132–135PubMedCrossRefGoogle Scholar
  6. Conrad C, Vianna C, Freeman M, Davies PA (2002) Polymorphic gene nested within an intron of the tau gene: implications for Alzheimer’s disease. Proc Natl Acad Sci U S A. 99(11):7751–7756PubMedCentralPubMedCrossRefGoogle Scholar
  7. Conrad C, Vianna C, Schultz C, Thal DR, Ghebremedhin E, Lenz J, Braak H, Davies P (2004) Molecular evolution and genetics of the Saitohin gene and tau haplotype in Alzheimer’s disease and argyrophilic grain disease. J Neurochem 89:179–188PubMedCrossRefGoogle Scholar
  8. Cook L, Brayne CE, Easton D, Evans JG, Xuereb J, Cairns NJ, Rubinsztein DC (2002) No evidence for an association between Saitohin Q7R polymorphism and Alzheimer’s disease. Ann Neurol 52(5):690–691PubMedCrossRefGoogle Scholar
  9. de Silva R, Hardy J, Crook J, Khan N, Graham EA, Morris CM, Wood NW, Lees AJ (2002) The tau locus is not significantly associated with pathologically confirmed sporadic Parkinson’s disease. Neurosci Lett 330(2):201–203PubMedCrossRefGoogle Scholar
  10. Ezquerra M, Gaig C, Ascaso C, Muñoz E, Tolosa E (2007) Tau and saitohin gene expression pattern in progressive supranuclear palsy. Brain Res 1145:168–176PubMedCrossRefGoogle Scholar
  11. Farrer M, Skipper L, Berg M, Bisceglio G, Hanson M, Hardy J, Adam A, Gwinn-Hardy K, Aasly J (2002) The tau H1 haplotype is associated with Parkinson’s disease in the Norwegian population. Neurosci Lett 322(2):83–86PubMedCrossRefGoogle Scholar
  12. Gao L, Tse SW, Conrad C, Andreadis A (2005) Saitohin, which is nested in the tau locus and confers allele-specific susceptibility to several neurodegenerative diseases, interacts with peroxiredoxin 6. J Biol Chem 280(47):39268–39272PubMedCrossRefGoogle Scholar
  13. Holzer M, Craxton M, Jakes R, Arendt T, Goedert M (2004) Tau gene (MAPT) sequence variation among primates. Gene 341:313–322PubMedCrossRefGoogle Scholar
  14. Johansson A, Zetterberg H, Håkansson A, Nissbrandt H, Blennow K (2005) TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer’s disease and are not associated with frontotemporal dementia or Parkinson’s disease. Neurodegener Dis 2(1):28–35PubMedCrossRefGoogle Scholar
  15. Levecque C, Elbaz A, Clavel J, Vidal JS, Amouyel P, Alpérovitch A, Tzourio C, Chartier-Harlin MC (2004) Association of polymorphisms in the Tau and Saitohin genes with Parkinson’s disease. J Neurol Neurosurg Psychiatry 75(3):478–480PubMedCentralPubMedCrossRefGoogle Scholar
  16. Lin K, Tang M, Guo Y, Han H, Lin Y, Ma C (2008) The Q7R polymorphism in the saitohin gene is rare in a southern Chinese population. Neurol Sci 29(6):431–434PubMedCrossRefGoogle Scholar
  17. Pankratz N, Nichols WC, Uniacke SK, Halter C, Rudolph A, Shults C, Conneally PM, Foroud T, Parkinson Study Group (2002) Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations. Am J Hum Genet 71:124–135PubMedCentralPubMedCrossRefGoogle Scholar
  18. Pepłońska B, Zekanowski C, Religa D, Czyzewski K, Styczyńska M, Pfeffer A, Gabryelewicz T, Gołebiowski M, Luczywek E, Wasiak B, Barczak A, Chodakowska M, Barcikowska M, Kuźnicki J (2003) Strong association between Saitohin gene polymorphism and tau haplotype in the Polish population. Neurosci Lett 348(3):163–166PubMedCrossRefGoogle Scholar
  19. Seripa D, Matera MG, D’Andrea RP, Gravina C, Masullo C, Daniele A, Bizzarro A, Rinaldi M, Antuono P, Wekstein DR, Dal Forno G, Fazio VM (2004) Alzheimer disease risk associated with APOE4 is modified by STH gene polymorphism. Neurology 62(9):1631–1633PubMedCrossRefGoogle Scholar
  20. Skipper L, Wilkes K, Toft M, Baker M, Lincoln S, Hulihan M, Ross OA, Hutton M, Aasly J, Farrer M (2004) Linkage disequilibrium and association of MAPT H1 in Parkinson disease. Am J Hum Genet 75(4):669–677PubMedCentralPubMedCrossRefGoogle Scholar
  21. Sonmez E, Ozel MD, Sazci A, Ergul E, Idrisoglu HA (2014) Association of saitohin gene rs62063857 variant with dementia. Neurobiol Aging 35:718–719CrossRefGoogle Scholar
  22. Streffer JR, Papassotiropoulos A, Kurosinski P, Signorell A, Wollmer MA, Tsolaki M, Iakovidou V, Hörndli F, Bosset J, Götz J, Nitsch RM, Hock C (2003) Saitohin gene is not associated with Alzheimer’s disease. J Neurol Neurosurg Psychiatry 74(3):362–363PubMedCentralPubMedCrossRefGoogle Scholar
  23. Tanahashi H, Asada T, Tabira T (2004) Association between tau polymorphism and male early-onset Alzheimer’s disease. NeuroReport 15(1):175–179PubMedCrossRefGoogle Scholar
  24. Tobin JE, Latourelle JC, Lew MF, Klein C, Suchowersky O, Shill HA, Golbe LI, Mark MH, Growdon JH, Wooten GF, Racette BA, Perlmutter JS, Watts R, Guttman M, Baker KB, Goldwurm S, Pezzoli G, Singer C, Saint-Hilaire MH, Hendricks AE, Williamson S, Nagle MW, Wilk JB, Massood T, Laramie JM, DeStefano AL, Litvan I, Nicholson G, Corbett A, Isaacson S, Burn DJ, Chinnery PF, Pramstaller PP, Sherman S, Al-hinti J, Drasby E, Nance M, Moller AT, Ostergaard K, Roxburgh R, Snow B, Slevin JT, Cambi F, Gusella JF, Myers RH (2008) Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. Neurology 71(1):28–34PubMedCentralPubMedCrossRefGoogle Scholar
  25. Verpillat P, Ricard S, Hannequin D, Dubois B, Bou J, Camuzat A, Pradier L, Frebourg T, Brice A, Clerget-Darpoux F, Deleuze JF, Campion D, French Study Group on Alzheimer’s Disease and Frontotemporal Dementia (2002) Is the saitohin gene involved in neurodegenerative diseases? Ann Neurol 52(6):829–832PubMedCrossRefGoogle Scholar
  26. Wang B, Zhou S, Yang Z, Xie YC, Wang J, Zhang P, Lv Z, Zheng C, Ma X (2008) Genetic analysis of tumor necrosis factor-alpha (TNF-alpha) G-308A and Saitohin Q7R polymorphisms with Alzheimer’s disease. J Neurol Sci 270(1–2):148–151PubMedCrossRefGoogle Scholar
  27. Wang Y, Gao L, Conrad CG, Andreadis A (2011) Saitohin, which is nested within the tau gene, interacts with tau and Abl and its human-specific allele influences Abl phosphorylation. J Cell Biochem 112(11):3482–3488PubMedCentralPubMedCrossRefGoogle Scholar
  28. Wider C, Vilariño-Güell C, Jasinska-Myga B, Heckman MG, Soto-Ortolaza AI, Cobb SA, Aasly JO, Gibson JM, Lynch T, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA (2010) Association of the MAPT locus with Parkinson’s disease. Eur J Neurol 17(3):483–486PubMedCentralPubMedCrossRefGoogle Scholar
  29. Zabetian CP, Hutter CM, Factor SA, Nutt JG, Higgins DS, Griffith A, Roberts JW, Leis BC, Kay DM, Yearout D, Montimurro JS, Edwards KL, Samii A, Payami H (2007) Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson’s disease. Ann Neurol 62(2):137–144PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Ezgi Sonmez
    • 1
  • Mavi Deniz Ozel
    • 1
  • Eylul Ece Islek
    • 1
  • Ali Sazci
    • 1
  • Halil Atilla Idrisoglu
    • 2
  1. 1.Departments of Medical Biology and Genetics, Faculty of MedicineUniversity of KocaeliKocaeliTurkey
  2. 2.Department of Neurology, Istanbul Faculty of MedicineUniversity of IstanbulCapaTurkey

Personalised recommendations